Skip to content
Menu

Emergent BioSolutions Inc. EBS

Full chart Compare
Set alert

Price alert · EBS

All alert types
5.05 USD -0.10 (-1.94%)

Regular-session close

5.05 0.00 0.00%

After hours · Nov 20, 4:00 PM ET

4.98 Day range 5.24
4.36 52-week range 14.06
YTD
-59.14%
1 year
-44.38%

Revenue & Expenses

Revenue by
Revenue Profit Costs
Gross Profit$350.60MCost of Revenue$392.30MNet Income$52.60MSelling, General & Admin$186.60MResearch & Development$53.80MOther Expenses$27.40MIncome Tax$30.20MRevenue$742.90MProduct$705.20MContracts and Grants$37.70M

Latest period ending Dec 31, 2025 · select a line to chart its full history

EBS annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
742.90M1.04B1.05B1.12B1.77B
416.70M362.30M343.90M424.40M1.03B
100.10M-108.70M-726.40M-170.00M341.40M
52.60M-190.60M-760.50M-211.60M219.50M
0.93-3.60-14.85-4.224.06
EBS annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
209.10M105.60M111.70M642.60M576.30M
1.32B1.39B1.82B3.17B2.96B
796.00M906.90M1.17B1.78B1.35B
572.10M663.70M860.20M1.41B841.00M
522.60M482.80M649.30M1.39B1.61B
EBS annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
170.60M58.70M-206.30M-34.10M320.20M
69.40M125.20M212.30M-381.30M-224.10M
-136.60M-190.00M-535.70M481.20M-141.00M
24.40M-15.00M-51.60M-115.80M-224.10M
103.50M-6.10M-530.90M66.30M-45.20M